Introduction
The lysosomal system is composed of several distinct and dynamically interacting vesicular compartments that are major sites for intracellular protein turnover and the limited proteolytic processing of certain proteins (deDuve et al., 1955) . Acid hydrolases of different enzyme classes, which are optimally active at acidic pH, mediate these processing events. The biosynthesis of lysosomes begins with the de novo synthesis of lysosomal hydrolases and membrane glycoproteins in the endoplasmic reticulum, followed by posttranslational modification and packaging in the Golgi apparatus. In a subsequent series of signaling and sorting processes, lysosomal enzymes bind to high affinity mannose-6-phosphate receptors (MPR) and exit the Golgi apparatus via coated vesicles (for review, see Kornfeld and Mellman, 1989; Geuze et al., 1988; Gruenberg and Howell, 1989) . These Golgi-derived vesicles containing nascent lysosomal hydrolase are selectively transported to a prelysosomal compartment, where the enzyme is dissociated from the receptor by acidification of the compartment (Brown et al., 1986; Dahms et al., 1989; Griffiths et al., 1990) .
The classical literature (deDuve and Wattiaux, 1966) categorizes lysosomes into three morphologically distinct compartments containing catalytically competent hydrolases. These compartments include primary lysosomes carrying only newly synthesized hydrolase, secondary lysosomes composed of enzyme and internalized material undergoing digestion (e.g., autophagic vacuoles, multivesicular/multilamellar bodies, and dense bodies), and tertiary lysosomes (e.g., lipofuscin) composed of residual, undigested material. More recent studies, however, reveal greater complexity, including the existence of distinct early and late endosomal compartments in addition to mature lysosomes (Dahms et al., 1989; Griffiths et al., 1990) . Acid hydrolases are abundant in late endosomes and mature lysosomes and are also present in lower amounts and in active form within early endosomes (Rodman et al., 1990; Diment et al., 1988; Lemansky et al., 1987; Bowser and Murphy, 1990) . In most cells, a small percentage of hydrolase escapes the receptor-mediated intracellular targeting to lysosomes and is routed through the secretory pathway (Hasilik, 1992) . Late endosomes undergo both fission and fusion with other endocytic corn partments and autophagic vacuoles, providing a link between endocytic and autophagic pathways (Gorden and Seglen, 1988; Deng et al., 1991) . Immunocytochemical studies (Cataldo et al., , 1994 Nixon et al., 1992 Bernstein et al., 1992; Nakamura et al., 1991) of lysosomal hydrolases have demonstrated abnormalities of the lysosomal system at early and late stages of AIzheimer's disease pathogenesis. Increased levels of lysosomal hydrolases of different enzyme classes and accumulation of acid hydrolase-containing compartments in at-risk populations of normal-appearing neurons precede the earliest known intracellular histopathological features of the disease and worsen as overt signs of degeneration appear (Nixon et al., 1992; Cataldo et al., 1994) . Following cell lysis, the liberation of cathepsin D (Cat D) and many other lysosomal hydrolases within secondary and tertiary lysosomes accounts for the abnormal extracellular presence of these enzymes in association with ~-amyloid deposits (Cataldo et al., 1994) . The persistence of acid hydrolase deposits in the extracellular space is, to our knowledge, a pathological phenomenon selectively related to AIzheimer's pathogenesis and other conditions associated with I~-amyloidogenesis (Nixon and Cataldo, 1991; Nixon et al., 1992; Villanova et al., 1993) . Additional changes in hydrotase expression may occur secondarily in astrocytes in Alzheimer's disease (Diedrich et al., 1991 ; Nakamura et al., 1991) ; however, histochemical, immunologic, and ultrastructural evidence indicates that degenerating neurons (Cataldo et al., , 1994 Nixon and Cataldo, 1991; Nixon et al., 1992) and their processes are the principal sources of extracellular hydrolase in plaques of Alzheimer's brain parenchyma. Most recently, we have found that Cat D levels in ventricular cerebrospinal fluid averaged 4-fold higher in Alzheimer's patients than in a control group of patients with Huntington's disease and other neurodegenerative diseases (Schwagerl and Nixon, unpublished data Beyond the abnormal phosphorylation of tau protein and formation of neurofibrillary tangles in some affected neurons, little is known about the early intraceliular events associated with Alzheimer's disease. In addition to providing information about these events, the possibility that the endosomal-lysosomal pathway in vulnerable neurons may be activated in Alzheimer's disease may have other implications for the pathogenesis of the disease. A major route of amyloid precursor protein (APP) processing and degradation is through the endosomal-lysosomal pathway Golde et al., 1992; Siman et al., 1993; Caporaso et al., 1992; Haass et ai., 1992; Cole et al., 1992) . Although the site of normal 13-amyloid peptide (AI3) generation is still unresolved, endosomal (Koo and Squazzo, 1994; Shoji et al., 1992) or late Golgi compartments (Buscaglio et al., 1993; have been proposed on the basis of indirect evidence. Although the responsible proteases are unknown, several cathepsins, some of which are known to be present in each of these compartments (Hasilik, 1992; Diment et al., 1988) , are among the candidates (Abraham et al., 1992; Tagawa et al., 1992; Ishiura, 1991; Ishiura et al., 1990; Schonlein et al., 1993; Ladror et al., 1994; Shi et al., 1994) . APP is also metabolized in lysosomes to smaller fragments containing the complete AI3 domain Caporaso et al., 1992) , which could be neurotoxic (Yankner et al., 1989; Neve et ai., 1992) or be an additional potential source of AI~, especially if lysosomal system function were disturbed (Cataldo et al., , 1994 Nixon et al., 1992; Tagawa et al., 1992) . Finally, the physiologic function and metabolism of apolipoprotein E, a major risk factor in Alzheimer's dis- ease (Corder et al., 1993; Strittmatter et al., 1993) , depends on the endosomal-lysosomal system (Ye et al., 1993) .
To test the hypothesis that t~e endosomal-lysosomal system is up-regulated early in Alzheimer's pathogenesis and to examine whether previous observations of abnormal lysosome hydrolase accumulation in neurons reflect decreased turnover or increased synthesis of lysosomal Ilydrolases, we measured the levels of expression of Cat D mRNA by in situ hybridization and Cat D protein levels by immunocytochemistry. Our results show that substantial increases in Cat D content detected immunocytochemically within at-risk populations of neurons in Alzheimer's brains are associated with marked up-regulation of Cat D gene expression in these same cell groups.
Results

Expression of Cat D-Specific mRNA in Neocortical
Neurons from Normal Human Brain Light microscopic inspection of hybridized tissue sections from the prefrontal cortices of control brains displayed a distribution of specific Cat D mRNA expression ( Figure 1 ) consistent with that of immunoreactive Cat D seen in our previous cytochemical studies (Cataldo et al., 1994; Nixon et al., 1992) . Cat D mRNA was most prominently localized in pyramidal neurons throughout all layers of the cortical mantle and varied little among neurons of different sizes ( Figure I ; also see Figure  3 ). Within these neurons, Cat D signal was high in neuronal cell bodies, low in the proximal dendrites (Figure 1 ), and undetectable in axons. Cat D m RNA levels were relatively low in nonpyramidal neurons of the prefrontal cortex (see below). Somewhat higher levels were detected in astrocytes identified by their nuclear size, shape, and chromatin pattern; however, compared with pyramidal neurons, astrocytes contained much lower Cat D message levels. Cat D signal was negligible to absent in sections from the same brain regions hybridized with the sense Cat D cRNA probe (Figure 1 ). No differences were observed between the quality and quantity of mRNA expression detected using biotin and digoxigenin-labeled Cat D RNA probes.
Markedly Increased Cat D mRNA Levels in At-Risk Neuronal Populations from Alzheimer's Brains Hybridized tissue sections from AIzheimer's brains exhibited prominent increases in specific Cat D mRNA signal in nearly all of the pyramidal neurons within layers III and V (Figure 1 ). The signal was exclusively intracellular and densest within the cell body and proximal dendrites, but also appeared in low levels within the basal dendrites. Most neurons expressing very high levels of signal expression displayed no evidence of atrophy or chromatolysis. In serial adjacent sections from Alzheimer's brains stained with Nissl (Figure 1) , silver, or thioflavin S stains, nonpyramidal neurons in cortical lamina IV had levels of Cat D mRNA that, by light microscopic inspection, were equivalent to the levels observed in age-matched control brains ( Figure 2 ). Consistent with other investigators (Diedrich et al., 1991; Nakamura et al., 1991; Bernstein et al., 1989 Bernstein et al., , 1992 , we detected an increased expression in the levei of Cat D mRNA within activated astrocytes by qualitative estimation. Modest increases in the level of glial Cat D signal were exhibited in both white and gray matter; however, Cat D mRNA levels in pyramidal neurons considerably exceeded those in astrocytes, in accord with previous immunocytochemical studies .
To estimate the magnitude of the message increase and the proportion of the pyramidal cell population affected, we used computer-assisted microdensitometry to measure the density of Cat D mRNA signal in 125 individual, at-risk pyramidal neurons in neocortical laminae layer Ill and separately in lamina V from five AIzheimer's brains and five control brains matched with respective postmortem interval and age of the individual. Greater than 94% of the pyramidal neurons in layer V and greater than 70% in layer III of the Alzheimer's brains displayed Cat D mRNA message densities that were 2 SD higher than the mean values measured in neurons of comparable size in control brains ( Figure 3A) . Small, medium, and large size pyramidal neurons displayed mRNA increases of similar magnitude. Elevations of Cat D mRNA levels ranged from 1.5-to 5-fold and for the whole population, averaged 2.5-fold higher than the mean value for the population of neurons analyzed in control cases (p < .001). Northern blot analyses on brain homogenates from the prefrontal cortices of five Alzheimer's and five control brains confirmed the presence of increased levels of Cat D mRNA in Alzheimer's brains compared with their agematched counterparts ( Figure 3A ). Relative Cat D levels were elevated an average of 35% in Alzheimer's cases (p < .05). Because of the extensive fallout of pyramidal neurons in the Alzheimer's cases and the substantial contribution of nonneuronal cells and unaffected neurons to the baseline Cat D mRNA levels, it was not unexpected that Northern blot analysis would underestimate the Cat D mRNA increase exhibited by the remaining pyramidal neurons and detected by in situ hybridization. Ribosomal Ioadings were identical. Hybridization with probes for other hydrolases (i.e., cathepsin B and hexcsaminidase A [data not shown]) did not reveal cross-hybridization with the 18S ribosomal species; however, if it did occur, because ribosomal loading was identical, cross hybridization would have added an equal amount to the signals obtained from Alzheimefs and control brains and would contribute to an underestimation of the differences between the two groups. The use of Northern blot analyses in this study was not intended to supply major quantitative evidence but to confirm that the Cat D probe hybridized well to a band of the expected size.
Abnormally High Cat D mRNA Expression Is Associated with Increased Cat D Content in Pyramidal Neurons from Alzheimer's Brains
Neocortical sections serially adjacent to those used in the in situ hybridization studies were immunolabeled with an antiserum against human brain Cat D. As in previous studies, Cat D immunoreactivity in he•cortical pyramids from layers III and V was increased to varying extents in lysosomal compartments that accumulate markedly within the soma, dendrites, and axon hillock (Figure 4 and see Figure  1 ; for further details, see Cataldo et al., 1994; Nixon et al., 1992) . Semiquantitative microdensitometric analyses of immunocytochemical reaction product indicated that the majority of pyramidal neurons in either laminae III or V in Alzheimer's neocortex displayed abnormally increased levels of immunoreactivity per cross-sectional perikaryal area compared with the same groups of neurons from the control brains. The mean density of immunoreaction product in neurons in the Alzheimer group averaged 1.5-fold higher than the control value (p < .001). The mean cross-sectional area of pyramidal neuron perikarya in AIzheimer's brains did not differ significantly from that in control brains (see Figure 3B; mer's cases showed that neu rofibrillary tangles were present in only 5%-18% of the neurons in layers III and V that contained elevated levels of both Cat D mRNA expression and immunoreactivity (data not shown). Degenerating neurons and their processes are a major source of extracellular Cat D associated within senile plaques (Cataldo et al., , 1994 Nixon et al., 1992) . We were unable, however, to detect the presence of Cat D-specific mRNA within most dying neurons associated with senile plaques or in Cat D-positive senile plaques identified by silver staining (data not shown). Intact pyramidal neurons displaying elevated Cat D mRNA levels were frequently in close proximity with, but were not part of, the senile plaques. Reactive astrocytes containing high Cat D mRNA levels were observed at the crown of senile plaques peripheral to the location of most of the Cat D immunoreactivity present in the plaque.
Discussion
The EndosomaI-Lysosomal System Is Up-Regulated in Alzheimer's Disease
Our results show that nearly all pyramidal neurons from layers III and V of Alzheimer's prefrontal cortex exhibit abnormally elevated Cat D mRNA levels, which average 2-to 3-fold higher than their counterparts in age-matched normal control neocortex. By contrast, the less vulnerable population of nonpyramidal neurons in lamina IV exhibited relatively normal Cat D expression and immunoreactive content. Increased hydrolase synthesis, therefore, at least partly explains the marked accumulation of Cat D and probably the increased content of many other acid hydrolases previously observed in pyramidal neurons in AIzheimer's brains (Cataldo et al., , 1994 Nixon and Cataldo, 1991 ; Nakamura et al., 1991) . In this regard, additional Northern blot analyses for Cat B, which is present by immunocytochemistry in neurons to a much greater extent than astrocytes, showed increases of greater magnitude in Alzheimer's brain compared with controls (A. M. C. and R. A. N., unpublished data). In the same neuron populations, hydrolase-laden vesicular compartments accumulate and have been shown by double-label confocal imaging to be primarily Cat D immunoreactive secondary lysosomes or prelysosomal compartments, rather than lipofuscin (A. M. C. and R. A. N., unpublished data). This agrees with other findings that lipofuscin, a relatively nonspecific concomitant of neurodegeneration, is only modestly increased in Alzheimer's disease (Mann et ai., 1984a (Mann et ai., , 1984b . Taken together, these findings are strong evidence that the endosomal-lysosomal system is abnormally activated in neuronal populations at risk to degenerate in Alzheimers disease. The observation that activation is evident in an extremely high percentage of cell populations and develops before neurofibrillary tangles or other signs of degeneration appear implies that these changes are an early stage of metabolic compromise in vulnerable neuronal populations.
Early Endosomal Up-Regulation in Relation to Alzheimer's Pathogenesis
Changes in acid hydrolase expression reflect the functioning of several different compartments of the endosomallysosomal system. Cat D and other hydrolases are abundant not only in lysosomes but in prelysosomal compartments, including early and late endosomes, where many hydrolases may exist in both proenzyme and mature forms (Lemansky et al., 1987; Riederer et al., 1994; Erickson and Blobel, 1983) . Although these various acidic vesicular compartments have certain distinguishing biochemical and morphotogic features, acid hydrolases cleave proteins within each of these compartments (Diment et al., 1988; Bowser and Murphy, 1990; Rodman et al., 1990; Leman-sky et al., 1987) . Acid hydrolases, like Cat D, are also present to some extent in the secretory pathway, although their activity is not known (Hasilik, 1992) . Studies of nonneuronal cells indicate that late endosomes and lysosomes are sites of convergence of the endocytic (heterophagic) and autophagic pathways (Gordon et al., 1992; Deng et al., 1991) . Therefore, up-regulation of hydrolase synthesis and lysosome biogenesis may reflect accelerated endocytosis, autophagy, or both. Each of these responses has been reported in relation to states of nutritional deprivation and a few neurodegenerative states (for review, see ; however, endosomal-lysosomal system activation, manifested by secondary lysosome accumulation, is not an essential concomitant of either apoptotic or necrotic cell death . The nature and magnitude of the lysosomal response in Alzheimer's disease and Down's syndrome are, in fact, uncommonly seen as features of neuronal cell death in many neuropathologic conditions . In this regard, corresponding immunocytochemical studies of other neurodegenerative diseases, including Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, and progressive supranuclear palsy (Nixon et al., 1992; li et al., 1993 ; A. M. C. and R. A. N., unpublished data) indicate relatively minor lysosomal accumulation in affected neuronal populations, even as these neurons are degenerating. Even less commonly described is the persistence of lysosomal compartments in the extracellular space as hydrolase-laden neurons degenerate (Cataldo et al., 1994) . To our knowledge, this feature has not been observed in conditions other than those in which 13-amyloid is deposited, and it therefore may be a useful diagnostic feature of the degenerative process in Alzheimer's disease and related ~-amyloidoses.
Although their triggering mechanisms are not well understood, autophagy and endocytosis are responses expected in cells chronically attempting to regenerate, catabolize injured membranes, and synthesize new membranes. Membrane dysfunction in Alzheimer's disease is suggested by alterations in membrane fluidity (Zubenko et al., 1987; Hajimohammadreza and Brammer, 1990) , lipids (Farooqui et al., 1988; Pettegrew, 1989) , lipolytic enzymes, and membrane and membrane-associated proteins (Bosman et al., 1991) , including mutations of APP (Castano et al., 1991; Goate et al., 1991) . Moreover, the extensive axon terminal degeneration and dendritic dystrophy in Alzheimer's disease, which may precede morphologic changes in neuronal perikarya, implies the breakdown and replacement of large areas of membrane surface. Accelerated membrane trafficking to and from the periphery may account for the easily detected endosomallysosomal system up-regulation in perikarya in a very high percentage of otherwise normal-appearing pyramidal neurons that display prominent accumulations of lysosomal compartments at the perikaryal level. The suspected importance of the apolipoprotein E (Apo E) genotype as a risk factor in Alzheimer's disease (Corder et al., 1993; Strittmatter et al., 1993) could also relate to its function in cholesterol transport and membrane synthesis (Serougne et al., 1976; Mahley, 1988) , which requires endosomal-lysosomal system activity (Ye et al., 1993) . Apo E synthesis in astrocytes and Apo E uptake by neurons are markedly up-regulated in response to neuronal injury (Diedrich et al., 1991; Muller and Minwegan, 1985; Poirer et al., 1993) , presumably to provide cholesterol for new membrane synthesis and regenerative processes (Mahley, 1988) . Finally, aging, a major risk factor in AIzheimer's disease, is associated with an additional modest upregulation of the lysosomal system (Matus and Green, 1987; Lajtha et al., 1992; Nakamura et al., 1989) , which would superimpose on the disease-related alterations of this system observed in our studies.
EndosomaI-Lysosoma! System Activation and APP Processing
Given the known localization of acid hydrolases in early and late endosomes as well as lysosomal compartments (Bowser and Murphy, 1990; Rodman et al., 1990; Lemansky et al., 1987) , up-regulation of the endosomal-lysosomal system is likely to influence the processing of APP. Lysosomes are a major site for the intracellular turnover of APP (Cole et al., 1992; Golde et al., 1992; Caporaso et al., 1992; Haass et al., 1992) , and regulated sorting of APP to lysosomes may determine functional levels of APP in cells as well as influence levels of secreted APP (Sambamurti et al., 1992; Golde et al., 1992; Caporaso et al., 1992) . Soluble forms of A~ 1-40, and possibly AJ~ 1-42 are normally secreted from certain cells (Shoji et al., 1992; Haass et al., 1992) , and indirect evidence exists that A~ 1-40 may be generated normal!y in a late-Golgi or endosoreal compartment by noncysteine proteases (Buscaglio et al., 1993; Koo and Squazzo, 1994) . Although the responsible proteases have not been definitively identified, certain cathepsins cleave model peptide sequences of APP at sites relevant to this process. Cat D was found recently to generate the N terminus in AI~ from a model peptide substrate (Ladror et al., 1994) , and this process was accelerated more than 70-fold when the two amino acid residues corresponding to the double mutation in a Swedish family with early-onset familiar Alzheimer's disease (Almquist et al., 1993; Lilius and Lannfelt, 1994) were substituted. Cathepsin S has also been implicated indirectly in A[3 formation (Shi et al., 1994) . APP processing within post-Golgi or mature lysosomal compartments also represents a route to the generation of potentially amyloidogenic fragments of APP containing the entire A~ domain (Caporaso et al., 1992; Siman et al., 1993; Estus et al., 1992) , some of which may be neurotoxic when expressed in high amounts (Yankner et al., 1989; Neve et al., 1992; Hayashi et al., 1992) . It should also be considered that the trafficking and processing of APP could change when ceils are stressed (Baskin et al., 1991) or injured. Up-regulated hydrolase synthesis, for example, might be expected to increase levels of certain enzymes in vesicular compartments that normally contain negligible or minimal levels, thereby greatly accelerating some normal or alternative processing events. Finally, in AIzheimer's disease, enzymatically competent lysosomal hydrolases are found in abnormal extracellular locations within both diffuse and classical amyloid-containing senile plaques (Cataldo et al., , 1994 . Dysregulation of normal processing pathways in degenerating neurons has been proposed as an additional route that may be responsible for the generation of AI3 or amyloidogenic fragments in these lesions (Cataldo et al., 1994; Nixon and Cataldo, 1991) .
Relationship of Cat D Expression to Endstage Alzheimer's Pathology
Degenerating neurons or their processes are a major source of extracellular Cat D and the various other lysosomal hydrolases and hydrolase activities in senile plaques (Cataldo etal., 1990; . However, the most intensely Cat D immunoreactive degenerated neurons in the plaques exhibit lowered Cat D mRNA levels, owing to depletion or breakdown of RNA accompanying the degenerative process and to the scavenging responses of infiltrative cells. Reactive gliosis consisting of increased numbers of hypertrophic astrocytes and the presence of reactive astrocytes at the crown of both cored and uncored senile plaques is a characteristic feature of Alzheimer's neuropathology (Beach et al., ~989; Dully et al., 1982) . Our results are consistent with earlier findings (Diedrich et al., 1991 ) that some astrocytes express higher levels of Cat D mRNA in Alzheimer's brain. Increased lysosomal hydrolase expression in these cells is observed in various degenerative states, suggesting that lysosomal system up-regulation may accompany the hyperplastic/hypertrophic response of astrocytes (Massacesi etal., 1988; Bever et al., 1989; Bernstein et al., 1992; Nakanishi et al., 1993) . Several lines of evidence indicate, however, that astrocytes are an additional but minor source of the extracellular hydrolases present in senile plaques compared with neurons. In cytochemical experiments involving doublelabeling techniques with glial fibrillary acidic protein and Cat D antisera, astrocyte cell bodies were most abundant at the crown of amyloid-containing senile plaques but were not present in the central portions of the plaque where Cat D immunoreactivity was highest . The molecular layer of the prefrontal cortex, for example, contains numerous nodules of strongly Cat D-positive astrocytes, which are not associated with extracellular hydrolase deposits (Cataldo et al., ~ 990) . Moreover, cathepsins H and G, proteases abundant in gila but not neurons, were not detectable extracellularty in senile plaques. Conversely, acid hydrolases that were abundant in neurons but absent or at much lower levels in glia (e.g., Hex A and cathepsin B) were well represented in plaques extracellularly.
Experimental Procedures
Tissue Postmortem brain tissue from the prefrontal cortex (Brodmann area 10) of ten individuals with the probable clinical diagnosis of AIzheimer's disease and nine age-matched (62-78 years) neurologically normal controls were used in this study. Tissue was procured from the Brain Tissue Resource Centers at McLean Hospital (Belmont, MA) and the University of Massachusetts Medical School (Worcester, MA) and the Neuropathology Core Facility of the Massachusetts Alzheimer's Disease Research Center (Massachusetts General Hospital, Boston, MA). Control brains ranged from 1200 to 1350 g in weight and exhibited no gross anatomical pathology and only minimal histopathological changes (0-3 neuritic plaques per low power field; 0-6 neurofibrillary tangles per low power field).
The presence and magnitude of neurodegeneration and neurofibrillary histopathology were confirmed on adjacent, serial paraffin sections from all brains analyzed using Nissl and Bielschowsky silver stains, and the diagnosis of Alzheimer's disease was established by the Consortium to Establish a Registry of Alzheimer's Disease criteria (Mirra et al., 1991) . The presence of the 13-amyloid protein was detected histologically using thioflavin S staining. Postmortem interval for all brain tissue employed was 0-6 hr, with a total fixation time of 2 weeks or less.
Antibodies
Immunocytochemical studies were performed on paraffin or vibratome sections using an antiserum directed against human brain CAT D. This antibody was raised in sheep, and its immunospecificity was confirmed as described in previous studies (Nixon and Marotta, 1984; .
Immunocytochemistry
Hydrolase immunoreactivity was demonstrated using a modification of the avidin-biotin technique of Hsu et al. (1981) and Vectastain kits (Vector Laboratories, Inc., Burlingame, CA), with diaminebenzidine as the chromagen. Negative controls consisted of tissue sections incubated in preimmune antisera or in the absence of primary antiserum.
Source and Labeling of Probes
cDNA for human Cat D was generously provided by Dr. P. Faust (1985) . Isolation of the plasmid DNA was performed by the general method outlined by Maniatis et al. (1989) . The Cat D clone, CDpSP64, which contained a 2.2 kb cDNA, was inserted into a pSP64 vector and oriented so that the SP6 promotor produced antisense Cat D cRNA. For the purpose of obtaining an RNA control probe, the Cat D insert was subcloned in the PGEM2 vector system (Promega) oriented so that transcription by T7 polymerase yielded a sense RNA probe.
The CDpSp64 was linearized with Kpnl so that the SP6 promotor would produce approximately 400 bp antisense cRNA. The labeled RNA was produced in a 100 p.I solution containing 40 mM Tris-HCI (pH 7.5), 6 mM MgCI2, 2 mM spermidine, 10 mM NaCI, 20 mM DTT, 1 mM ATP, 1 mM GTP, 1 mM CTP, and 1 mM either biotinylated or digoxigenin conjugated UTP, together with 0.1 mM UTP, 100 U of RNAsin ribonuclease inhibitor, 2 v.g linearized plasmid DNA, and 200 U of SP64 RNA polymerase and incubated for 90 min at 37°C. After incubation, 0.38 v 10 N ammonium acetate, 2.5 v ethanol, and 1 ~l of concentrated glycogen (Boehringer-Mannheim) was added, and after incubation at 4°C for 30 rain, the precipitate was recovered by centrifuging for 10 min at 10,000 x g. The RNA was redissolved in 100 p.I of 1 M ammonium acetate and reprecipitated as described above. In some cases, the DpSP64 was cut with EcoR1, and the resultant 2.2 kb RNA product was digested to an average size of 400 bp by limited alkaline hydrolysis (Cox et al., 1984) .
In Situ Hybridization and Detection
The protocol employed for in situ hybridization and detection employed a modified hapten affinity cytochemical technique using biotinstreptavidin and digoxigenin antibodies (Boehringer-Mannheim Biochemicals, Mannheim, Germany) and the kit detection system of Gibco BRL (Life Technologies, Inc., Gaithersburg, ME)). Deparaffinized sections were washed in phosphate-buffered saline (PBS; pH 7.4) twice for 5 min each and transferred to 0.2 M Tris-HCL plus glycine (pH 7.4) for 10 min. After a brief rinse in PBS, slides were incubated in predigested (40 rain) proteinase K (40 p~g/ml) for 10 min at 37°C. Sections were immersed for 1 min in 4% paraformaldehyde/PBS (pH 7.4) at room temperature, rinsed for 5 min in PBS, and dehydrated through a series of alcohols. Tissue sections selected as negative controls were incubated for 45 min at 37°C in RNAase (20 ~g/ml) or were hybridized with a sense RNA probe. Positive control slides for the biotinylated RNA probes were included in the system and consisted of paraffin-embedded HeLa cells infected with adenovirus type 2. The slides were hybridized in sealed humidity chambers for 4-5 hr at 42°C. Following hybridization, the slides were rinsed in 1 M SSC and incubated in RNAse for 30 min at 37°C. Tissue sections then were rinsed three times briefly in 0.2 M SSC and again in 0.2 M SSC for two 10 rain washes. Sections were blocked for 20 min at room temperature and incubated for 1-2 hr in either the streptavidin-alkaline phosphatase conjugate or digoxigenin-alkaline phosphatase conjugate. Slides were rinsed twice for 15 rain each and then briefly for 5 rain in alkaline substrate buffer containing Trizma base, sodium chloride, and magnesium chloride (pH 9.5), followed by incubation in the reaction mixture (200 Id nitroblue tetrazolium and 166 ~1 4-bromo-5-chloro-3-indolylphosphate/50 ml alkaline substrate buffer) for 1-3 hr at 37°C. Color development was stopped by rinsing sections in deionized water. The tissue was dehydrated through ethanols, air dried, and coverslipped with an aqueous mounting medium. All solutions were prepared in diethyl pyrocarbonate-treated autoclaved water and passed through sterile 0.22 p,m filters before use.
Northern Blot Analysis
Total cytoplasmic RNAs were isolated with TRI Reagent (Molecular Research Center, Cincinnati, OH) from flash frozen blocks of the prefrontal cortices from Alzheimer's and control brains following the suggested protocol of the manufacturer. The Northern blot analyses were conducted according to the procedure described by DuPont NEN Research Products (Boston, MA) for Genescreen Plus. In brief, the RNAs (60 p.g for each) were separated on a 1% formaldehyde denaturing agarose gel and transferred to the GeneScreen Plus nylon membrane, and the blot was hybridized with the specific cDNA probe (109 to 2 x 101° cpm/llg, 106 cpm/p.I). The cDNA probe was labeled with ~2P-dCTP (DuPont NEN Research Products) using the Random Primer Kit (Boehringer-Mannhein Biochemicals, indianapolis, IN). The blot was subsequently washed and exposed to X-ray film (Kodak).
G ross loading errors would be unlikely using 60 p.g of RNA; however, as an additional loading control, gels were stained with ethidium bromide prior to transfer to confirm that ribosomal bands were identical in thickness and intensity. To detect cross-hybridization or comigration of Cat D with the 18S ribosomal species, additional hybridization studies were performed using probes for cathepsin B and hexosaminidase A.
Densitometric Analysis
Paraffin sections from the prefrontal cortices of Alzheimer's and agematched control brains were analyzed by densitometric analyses. Immediate adjacent serial sections immunolabeled with anti-Cat D antiserum were hybridized with the specific human digoxigenin-labeled Cat D RNA probe (above) to detect mRNA expression using in situ hybridization. The sections were coded and analyzed blindly with a userinteractive, IBM DEK 486 computer-assisted microdensitometric technique. The prefrontal cortices were viewed with a Leitz Laboriux 12 light microscope interfaced with a Bioquant Meg IV image analysis operating system (OS.2 Bioquant version 1.57, R and M Biometrics, Nashville, TN) via a Dege MTI CCD-72 solid state digital camera using a mouse/keyboard determination system to outline each neuron. Determinations were done in reversed polarity so that dense areas on the slides appeared as light areas on the video monitor. A 100x oil immersion objective (nA 1.518) was used to identify pyramidal neurons from laminae III and V of the prefrontal cortex (Brodmann Area 10) in both immunolabeled and hybridized tissue sections. The image system was calibrated by placing an image box over laminae of interest and recording the optical density (expressed as 0-255 levels of gray scale; 0, lowest density; 255, highest density).
A total of 25 small, medium, and large neurons with visibly defined nuclei were selected at random from layers ill and V of each brain. With the aid of the computer imaging system, the perimeter of each neuron was digitized and the area (in square micrometers) recorded. For each neuron, a second tracing was made by outlining the nucleus. The average optical density representing the total area of the neuron and the total area density minus the optical density of the nucleus was recorded. For each field, an image box was placed in various background regions and the average optical density measured. Statistical computations were performed using Student's t test.
